Posted inMarket
Roku Senior Vice President and General Counsel Handman Sells Over $460K in Company Stock
Roku Senior Vice President and General Counsel Stephen Handman recently executed a significant stock sale worth approximately $466764.
Posted inMarket
Fulgent Genetics CSO Hanlin Gao Offloads Stock Valued at Over 32000 Dollars
Discover the recent insider trading activity as Fulgent Genetics Chief Scientific Officer Hanlin Gao sells company stock worth over 32000 dollars.
Posted inMarket
Fulgent Genetics COO Xie Jian Executes Stock Sale Valued at Over $41000
Discover the details of Fulgent Genetics President and COO Xie Jian recent stock transaction involving shares valued at $41809.
Posted inMarket
MPM BioVentures 2018 Disposes of Entrada Therapeutics Shares Worth $617k
Explore the recent financial transaction involving MPM BioVentures 2018 selling $617,000 worth of Entrada Therapeutics shares in the market.
Posted inMarket
Ooma SVP Jenny Yeh Executes Stock Sale Worth Over 28000 Dollars
Discover recent insider trading updates as Ooma Senior Vice President Jenny Yeh sells company shares valued at over 28000 dollars.
Posted inMarket
Amalgamated Financial SEVP Sam Brown Sells Fractional Stock
Discover the latest insider trading update for Amalgamated Financial as SEVP Sam Brown executes a sale of fractional stock shares.
Posted inMarket
Ooma SVP Shuts Out Shares Worth Over 100000 Dollars in Recent Transaction
Discover the latest insider trading details regarding Ooma as a senior vice president sells over 107000 dollars in company shares.
Posted inMarket
MPM BioVentures Executes Significant Share Sale in Entrada Therapeutics
Discover the latest insider trading activity as major shareholder MPM BioVentures sells over six hundred thousand dollars in Entrada Therapeutics stock.
Posted inMarket
Dynaresource Director Gareth Nichol Secures Common Stock Shares
Discover the latest insider trading details as Dynaresource Director Gareth Nichol acquires common stock shares. Read the full financial report.
Posted inMarket
Bayview Legacy Sells $2.07 Million in Arteris Stock
Bayview Legacy, a 10 percent owner of Arteris, recently executed a stock sale valued at approximately $2.07 million. Discover the transaction details.
